Glenmark gets first generic approvals for Advair MDI

While a recent FDA draft guidance raised hopes that cut-price versions of GlaxoSmithKline's blockbuster asthma/COPD product Advair (fluticasone/salmeterol) may arrive earlier than anticipated in the US, the Indian company, Glenmark, has received what's perhaps the first approval for a generic Advair MDI (metered-dose inhaler) in Mexico and the Philippines.